VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans

被引:91
|
作者
Limdi, Nita A. [1 ]
Beasley, T. Mark [2 ]
Crowley, Michael R. [3 ]
Goldstein, Joyce A. [4 ]
Rieder, Mark J. [5 ]
Flockhart, David A. [6 ]
Arnett, Donna K. [7 ]
Acton, Ronald T. [8 ]
Liu, Nianjun [2 ]
机构
[1] Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Genet, Birmingham, AL 35294 USA
[4] NIEHS, Lab Pharmacol & Chem, Res Triangle Pk, NC USA
[5] Univ Washington, Dept Genome Sci, Washington, DC USA
[6] Indiana Univ, Sch Med, Div Clin Pharmacol, Bloomington, IN 47405 USA
[7] Univ Alabama, Dept Epidemiol, Birmingham, AL USA
[8] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA
关键词
African-Americans; cohort study; CYP2C9; European-Americans; pharmacogenetics; VKORC1; haplotypes; warfarin;
D O I
10.2217/14622416.9.10.1445
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Although the influence of VKORC1 and CYP2C9 polymorphisms on warfarin response has been studied, variability in dose explained by CYP2C9 and VKORC1 is lower among African-Americans compared with European-Americans. This has lead investigators to hypothesize that assessment of VKORC1 haplotypes may help capture a greater proportion of the variability in dose for this under-represented group. However, the inadequate representation of African-Americans and the assessment of a few VKORC1 polymorphisms have hindered this effort. Methods: To determine if VKORC1 haplotypes or haplotype groups explain a higher variability in warfarin dose, we comprehensively assessed VKORC1 polymorphisms in 273 African-Americans and 302 European-Americans. The influence of VKORC1 polymorphisms, race-specific haplotypes and haplotype groups on warfarin dose was evaluated in race-stratified multivariable analyses after accounting for CYP2C9 (*2, *3, *5, *6 and *11) and clinical covariates. Results: VKORC1 explained 18% (30% with CYP2C9) variability in warfarin dose among European-Americans and 5% (8% with CYP2C9) among African-Americans. Four common haplotypes in European-Americans and twelve in African-Americans were identified. In each race VKORC1 haplotypes emerged into two groups: low-dose (Group A) and high-dose (Group 13). African-Americans had a lower frequency of Group A haplotype (10.6%) compared with European-Americans (35%, p < 0.0001). The variability in dose explained by VKORC1 haplotype or haplotype groups was similar to that of a single informative polymorphism. Conclusions: Our findings support the use of CYP2C9, VKORC1 polymorphisms (rs9934438 or rs9923231) and clinical covariates to predict warfarin dose in both African- and European-Americans. A uniform set of common polymorphisms in CYP2C9 and VKORC1, and limited clinical covariates can be used to improve warfarin dose prediction for a racially diverse population.
引用
收藏
页码:1445 / 1458
页数:14
相关论文
共 50 条
  • [1] Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans
    Limdi, Nita A.
    KArnett, Donna
    Goldstein, Joyce A.
    Beasley, T. Mark
    McGwin, Gerald
    Adler, Brian K.
    Acton, Ronald T.
    [J]. PHARMACOGENOMICS, 2008, 9 (05) : 511 - 526
  • [2] Influence of CYP2C9 genotype on warfarin dose among African-Americans and European-Americans
    Limdi, Nita A.
    Goldstein, J. A.
    Blaisdell, J. A.
    Beasley, T. M.
    Rivers, C. A.
    Acton, R. T.
    [J]. PERSONALIZED MEDICINE, 2007, 4 (02) : 157 - 169
  • [3] Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array
    Liu, Nianjun
    Irvin, Marguerite R.
    Zhi, Degui
    Patki, Amit
    Beasley, T. Mark
    Nickerson, Deborah A.
    Hill, Charles E.
    Chen, Jinbo
    Kimmel, Stephen E.
    Limdi, Nita A.
    [J]. PHARMACOGENOMICS, 2017, 18 (11) : 1059 - 1073
  • [4] Effect of CYP2C9 and VKORC1 polymorphisms on warfarin dose, anticoagulation attainment and maintenance among European American and African Americans
    Limdi, N. A.
    Beasley, M.
    Goldstein, J. A.
    Arnett, D. K.
    McGwin, G.
    Acton, R. T.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (03) : 612 - 613
  • [5] Differences in startle reflex and prepulse inhibition in European-Americans and African-Americans
    Hasenkamp, Wendy
    Norrholm, Seth D.
    Green, Amanda
    Lewison, Barbara
    Boshoven, William
    Keyes, Megan
    Duncan, Erica
    [J]. PSYCHOPHYSIOLOGY, 2008, 45 (05) : 876 - 882
  • [6] Platelet reactivity in response to aspirin and ticagrelor in African-Americans and European-Americans
    Margaret Infeld
    Kevin A. Friede
    Tan Ru San
    Holly J. Knickerbocker
    Geoffrey S. Ginsburg
    Thomas L. Ortel
    Deepak Voora
    [J]. Journal of Thrombosis and Thrombolysis, 2021, 51 : 249 - 259
  • [7] A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African Americans
    Voora, D.
    Koboldt, D. C.
    King, C. R.
    Lenzini, P. A.
    Eby, C. S.
    Porche-Sorbet, R.
    Deych, E.
    Crankshaw, M.
    Milligan, P. E.
    McLeod, H. L.
    Patel, S. R.
    Cavallari, L. H.
    Ridker, P. M.
    Grice, G. R.
    Miller, R. D.
    Gage, B. F.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (04) : 445 - 451
  • [8] Platelet reactivity in response to aspirin and ticagrelor in African-Americans and European-Americans
    Infeld, Margaret
    Friede, Kevin A.
    San, Tan Ru
    Knickerbocker, Holly J.
    Ginsburg, Geoffrey S.
    Ortel, Thomas L.
    Voora, Deepak
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 51 (02) : 249 - 259
  • [9] The angle of the articular eminence in modern dentate African-Americans and European-Americans
    Jasinevicius, TR
    Pyle, MA
    Lalumandier, JA
    Nelson, S
    Kohrs, KJ
    Sawyer, DR
    [J]. CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE, 2005, 23 (04): : 249 - 256
  • [10] Perceptions of genetics research as harmful to society: Differences among samples of African-Americans and European-Americans
    Furr, LA
    [J]. GENETIC TESTING, 2002, 6 (01): : 25 - 30